Press release
mRNA Vaccines and Therapeutics Market Size is Projected to Reach USD 85.9 billion, Advancing at a 14.6% CAGR by 2034: TMR Report
Messenger RNA (mRNA) vaccines and therapeutics represent a revolutionary advancement in the field of biotechnology and medicine. Unlike traditional vaccines, mRNA vaccines utilize synthetic mRNA to instruct cells to produce proteins that trigger an immune response. This novel approach has been successfully demonstrated in the development of COVID-19 vaccines, significantly accelerating the timeline from development to deployment. Beyond vaccines, mRNA therapeutics hold promise for treating a wide range of diseases, including cancer, infectious diseases, and genetic disorders. This article explores the current state and future prospects of the mRNA vaccines and therapeutics market.mRNA Vaccines and Therapeutics Market (mRNA 백신 및 치료제 시장) is anticipated to advance at a CAGR of 14.6% from 2024 to 2034 and reach US$ 85.9 Bn by the end of 2034
Download Sample of the Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86317
Overview of mRNA Vaccines and Therapeutics Market
The global mRNA vaccines and therapeutics market has experienced rapid growth, primarily driven by the COVID-19 pandemic and the successful deployment of mRNA vaccines by companies such as Pfizer-BioNTech and Moderna. The market is segmented by application (infectious diseases, oncology, genetic disorders, others), end-users (hospitals, clinics, research institutes, pharmaceutical companies), and geographical regions.
Market Key Players
Moderna, Inc.
BioNTech SE.
CureVac SE
Arcturus Therapeutics, Inc.
Sanofi
GSK plc
Argos Therapeutics Inc.
Ethris
Pfizer Inc.
AstraZeneca
Recent Developments in mRNA Vaccines and Therapeutics Market
Recent advancements and trends in the mRNA vaccines and therapeutics market include:
COVID-19 Vaccines: The rapid development and widespread distribution of mRNA vaccines for COVID-19 have demonstrated the platform's potential, paving the way for future mRNA-based vaccines.
Oncology Applications: Ongoing research and clinical trials exploring mRNA therapeutics for cancer treatment, including personalized cancer vaccines and immunotherapies targeting specific tumor antigens.
Infectious Disease Pipeline: Expansion of the mRNA vaccine pipeline to include vaccines for other infectious diseases such as influenza, Zika virus, and cytomegalovirus (CMV).
Genetic Disorders: Development of mRNA therapeutics for rare genetic disorders, aiming to provide treatment by correcting or compensating for defective genes.
Manufacturing Innovations: Advancements in mRNA manufacturing technologies, including scalable production processes and improved stability of mRNA molecules.
Drivers of Market Growth
Several factors contribute to the growth of the mRNA vaccines and therapeutics market:
Technological Advancements: Continuous innovations in mRNA technology, including improved delivery systems, enhanced stability, and targeted delivery mechanisms.
COVID-19 Impact: The global response to the COVID-19 pandemic has accelerated investment, research, and regulatory pathways for mRNA vaccines and therapeutics.
Versatility of mRNA Platform: The versatility and adaptability of the mRNA platform to address a wide range of diseases, including infectious diseases, cancer, and genetic disorders.
Funding and Investment: Significant funding and investment from governments, private investors, and pharmaceutical companies to support the development and commercialization of mRNA-based products.
Public and Regulatory Support: Increasing public awareness and regulatory support for mRNA vaccines and therapeutics, fostering a favorable environment for market growth.
Explore Sample of the Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86317
Conclusion
The mRNA vaccines and therapeutics market is poised for significant growth, driven by technological advancements, the impact of the COVID-19 pandemic, the versatility of the mRNA platform, substantial funding and investment, and increasing public and regulatory support. Innovations in manufacturing, oncology applications, infectious disease pipelines, genetic disorder treatments, and personalized medicine are enhancing the effectiveness and accessibility of mRNA-based products.
Market Segmentation
mRNA Type
Nucleoside-modified mRNA
Unmodified mRNA
Self-amplifying mRNA
Type
Prophylactic
Therapeutic
Application
Infectious Diseases
Oncology
Rare Genetic Diseases
Others (Respiratory Diseases, etc.)
End-user
Hospitals & Clinics
Biopharmaceutical Companies
Others (Research Organizations, etc.)
Region
North America
Latin America
Europe
Asia Pacific
Middle East & Africa
Buy this Premium Research Report:
https://www.transparencymarketresearch.com/checkout.php?rep_id=86317<ype=S
More Trending Report by Transparency Market Research:
Urinary Tract Disorders Propels Ureteral Stents Market (尿路疾患が尿管ステント市場を牽引): https://www.globenewswire.com/news-release/2024/07/05/2909009/32656/en/Rising-Incidence-of-Urinary-Tract-Disorders-Propels-Ureteral-Stents-Market-to-Achieve-USD-823-7-Million-by-2031-Transparency-Market-Research-Inc.html
Cryotherapy Market (Marché de la cryothérapie): https://www.globenewswire.com/en/news-release/2024/07/03/2908096/32656/en/Cryotherapy-Market-to-be-Worth-USD-885-7-million-by-2034-Growing-a-CAGR-9-3-Exclusive-Report-by-Transparency-Market-Research-Inc.html
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release mRNA Vaccines and Therapeutics Market Size is Projected to Reach USD 85.9 billion, Advancing at a 14.6% CAGR by 2034: TMR Report here
News-ID: 3588631 • Views: …
More Releases from Transparency Market Research
Europe Anti-slip Paper Market Valuation Set to Reach USD 450.1 Million by 2035, …
The Europe Anti-slip Paper Market is poised for robust growth over the forecast period, driven by rising demand for sustainable, efficient, and safe packaging solutions across industries. Valued at US$ 214.4 Mn in 2024, the market is projected to almost double and touch US$ 450.1 Mn by 2035, registering a CAGR of 7.0% from 2025 to 2035. This growth is supported by stringent regulatory frameworks, the rapid expansion of e-Commerce,…
Ethyl Acetate Market Outlook 2035: Global Valuation to Reach USD 15.1 Billion Am …
The global ethyl acetate market is entering a phase of sustained expansion driven by strong industrial demand and accelerating adoption of green, sustainable solvents. Valued at US$ 6.5 Bn in 2024, the market is projected to expand at a CAGR of 8.0% from 2025 to 2035, ultimately reaching US$ 15.1 Bn by 2035. This growth reflects rising use across paints and coatings, adhesives, pharmaceuticals, packaging, and the food & beverage…
HPLC Column Market Outlook 2035: Global Industry to Reach USD 4.7 Billion by 203 …
The global HPLC Column Market is poised for steady and sustained growth through 2035, supported by rising demand for analytical testing across pharmaceutical, biotechnology, food and beverages, and environmental sectors. Valued at US$ 2.6 Bn in 2024, the industry is projected to reach US$ 4.7 Bn by 2035, expanding at a CAGR of 5.3% from 2025 to 2035. Increasing regulatory compliance, technological advancements in column design, and growing applications in…
Carboxylic Acid Market Outlook 2035: Global Market to Reach USD 12.9 Billion by …
The global carboxylic acid market continues to gain momentum as demand surges across diverse industrial applications. Valued at US$ 6.6 Bn in 2024, the market is projected to expand at a CAGR of 6.3% between 2025 and 2035, ultimately reaching US$ 12.9 Bn by 2035. This strong growth trajectory is driven by the rising consumption of carboxylic acids in chemicals, food and beverages, pharmaceuticals, agriculture, personal care, and industrial manufacturing.…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
